Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis

Edward Mpoza, Joshua Rhein, Mahsa Abassi

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


We present the case of an HIV-seropositive individual with cryptococcal meningitis who was found to have a fluconazole resistant strain of Cryptococcus neoformans. The individual required multiple rounds of amphotericin and fluconazole 800–1200 mg after several episodes of clinical relapse. Cerebrospinal fluid sterilization was achieved and maintained with high doses of fluconazole. This case demonstrates the emerging dilemma of increasing rates of fluconazole resistance in Cryptococcus and the clinical difficulties in meningitis management.

Original languageEnglish (US)
Pages (from-to)30-32
Number of pages3
JournalMedical Mycology Case Reports
StatePublished - Mar 2018

Bibliographical note

Funding Information:
We would like to thank Drs. Lillian Tugume, Reuben Kiggundu, Kenneth Ssebambulidde, and the ASTRO-CM team for their medical care. We also thank Andrew Akampurira, Tonny Luggya, Kizza Tadeo and the Makerere University Medical School Microbiology Laboratory team. We thank Drs. David Boulware and David Meya for their support in assisting with the drafting of the manuscript, and their input into the intellectual content. Support for this project was received via: the National Institutes of Neurologic Diseases and Stroke and Fogarty International Center (R01NS086312, K01TW010268, R25TW009345).

Publisher Copyright:
© 2017


  • Antifungal susceptibility
  • Cryptococcal meningitis
  • Cryptococcal meningitis relapse
  • Cryptococcus
  • Fluconazole resistance


Dive into the research topics of 'Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis'. Together they form a unique fingerprint.

Cite this